← Open Payments lookup

PAIGE BENNETT: Open Payments

NPI 1356019285 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,410 in 114 payments from 18 companies in 2025. Trend: 2023 $1,565 · 2024 $1,131 · 2025 $2,410

Food & beverage: $2,410
CompanyPaymentsAmount
ABBVIE INC.27$416
E.R. Squibb & Sons, L.L.C.17$368
Neurocrine BioSciences, Inc.15$295
Teva Pharmaceuticals USA, Inc.8$272
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$237
Supernus Pharmaceuticals, Inc.5$199
Corium, LLC7$187
Lundbeck LLC5$105
Axsome Therapeutics, Inc.4$78
Otsuka America Pharmaceutical, Inc.4$74

Products named: VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, CAPLYTA, Qelbree, Azstarys, REXULTI.

Industry payments across TX — which companies pay providers there.